← Eichor
Condition: Granulomatosis With Polyangiitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Granulomatosis With Polyangiitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
Phase 3 · 2 location(s) · Ottawa Hospital Research Institute · NCT06983821Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Phase 2 · 35 location(s) · Novartis Pharmaceuticals · NCT06868290Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Phase 4 · 22 location(s) · Chiba University · NCT06611696A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Phase 3 · 15 location(s) · AstraZeneca · NCT06512883Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Phase 2 · 1 location(s) · National Jewish Health · NCT02947945VCRC Tissue Repository
Phase N/A · 8 location(s) · University of Pennsylvania · NCT02967068Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associate
Phase 1 · 1 location(s) · IRIS Research and Development, LLC · NCT06581562eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06298448The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangii
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07275190Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06350110Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Phase N/A · 10 location(s) · Peter Merkel · NCT03004326Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912One-Time DNA Study for Vasculitis
Phase N/A · 14 location(s) · University of Pennsylvania · NCT01241305Special Drug Use-results Survey for Long-term Use（Avacopan）
Phase N/A · 1 location(s) · Kissei Pharmaceutical Co., Ltd. · NCT06758271Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Phase N/A · 13 location(s) · University of Pennsylvania · NCT00315380A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （
Phase 2/Phase 3 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT05979051Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic A
NA · 45 location(s) · Hospices Civils de Lyon · NCT03290456Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04871191Ocular Manifestations of Granulomatosis With Polyangiitis.
Phase N/A · 1 location(s) · Military Institute od Medicine National Research Institute · NCT07664709Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06940661Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Phase 2 · 1 location(s) · NYU Langone Health · NCT07138898
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.